RT Journal Article
SR Electronic
T1 How do Hemodialysis Center Prevent the Secondary COVID-19 Transmission in Poverty-Stricken Rural Region of China: Experiences and Strategies
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.09.21252639
DO 10.1101/2021.03.09.21252639
A1 Gu, Yue
A1 Wang, Yuming
A1 Zhou, Jing
A1 Deng, Yaorui
A1 Shao, Fengmin
YR 2021
UL http://medrxiv.org/content/early/2021/03/12/2021.03.09.21252639.abstract
AB The COVID-19 pandemic has caused an evolving public health crisis and challenged the medical system globally, especially in the rural-stricken regions. There is concern about the spread of coronavirus in regions with lower education level, weaker health systems and underdeveloped economy. The risk of viral transmission in HD center is elevated because of the densely-populated and high mobility in an enclosed environment.This paper demonstrated the main experiences and strategies of preventing secondary COVID-19 transmission in a HD center from a poverty-stricken rural region in China. Data of subjects including 17 medical workers and 249 patients were collected from the HD center in Huangchuan County People’s Hospital from February to April 2020. It is the first paper to provide the experiences and strategies about preventing COVID-19 secondary transmission in HD center for poverty-stricken rural region.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNational Key R&D Program of China (2018YFC0114503) Joint Project of Medical Science and Technology Research Program of Henan Province (LHGJ20190617)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Medical Ethics Committee of Henan Provincial People's HospitalAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data and information described in the paper is open to public.